CLINICAL_TRIALS
trial_result
· 2021-04-28
Clinical Trial Update: BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence [Phase 2]
Summary
Phase 2 trial evaluating BOTOX (onabotulinumtoxinA) for reduction of masseter muscle prominence has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Masseter Muscle Prominence | Phase 2 | Status: COMPLETED | Results posted: 2021-04-28